New antibiotic tested for dangerous diabetic foot infections
NCT ID NCT04714411
Summary
This study tested the safety and effectiveness of the antibiotic omadacycline for treating moderate-to-severe diabetic foot infections, sometimes with bone infection. It involved 42 hospitalized patients and compared their outcomes to past patients who received standard antibiotic treatments. The main goal was to see if this antibiotic caused fewer kidney problems or a specific gut infection compared to other antibiotics.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC FOOT INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Methodist Charlton Medical Center
Dallas, Texas, 75237, United States
-
Methodist Dallas Medical Center
Dallas, Texas, 75203, United States
Conditions
Explore the condition pages connected to this study.